JSPR Jasper Therapeutics, Inc.

Fundamentals / CIK 0001788028 / USD
Other share classes on CIK 0001788028: JSPRW

Jasper Therapeutics, Inc. reported $147.4M in total assets and a net loss of $157.5M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open JSPR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$70.87MFY 2020 Net Income: -$31.67M2020FY 2021 Net Income: -$30.64M2021FY 2022 Net Income: -$37.69M2022FY 2023 Net Income: -$64.47M2023FY 2024 Net Income: -$71.27M2024FY 2025 Net Income: -$75.80M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cost of Revenue $41.63M $34.27M -- -- -- --
Research & Development $63.10M $55.82M $51.78M $34.63M $25.42M $15.88M
Total Operating Expenses $83.88M $76.24M $68.86M $51.20M $36.83M $20.68M
Operating Income -$83.88M -$76.24M -$68.86M -$51.20M -$36.83M -$20.68M
EBITDA -$82.83M -$74.87M -$67.75M -$50.22M -$36.46M --
Interest Income $1.74M $5.06M $5.20M $701K -- --
Income Before Tax -- -- -- -- -- -$552K
Income Tax Expense -- $2.0K $2.0K -- -- $38K
Net Income -$75.80M -$71.27M -$64.47M -$37.69M -$30.64M -$31.67M
Basic EPS -$3,379.45 -$4,183.67 -$5,287.34 -$8,837.90 -$23,014.47 -$44,232.27
Diluted EPS -$3,379.45 -$4,183.67 -$5,287.34 -$8,837.90 -$23,014.47 -$44,232.27
Basic Shares Outstanding 22.4K 17.0K 12.2K 4.3K 1.3K 716
Diluted Shares Outstanding 22.4K 17.0K 12.2K 4.3K 1.3K 716

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $8.00M -- -- -- -- -- -- --
Cost of Revenue $4.32M $3.58M $3.62M $6.76M $9.35M $15.77M $9.76M --
Gross Profit $3.68M -- -- -- -- -- -- --
Research & Development $8.33M $5.13M $5.81M $11.36M $14.39M $21.20M $16.16M $19.77M
Total Operating Expenses $152.2M $9.21M $10.95M $15.84M $19.17M $27.08M $21.80M $25.29M
Operating Income -$144.2M -$9.21M -$10.95M -$15.84M -$19.17M -$27.08M -$21.80M -$25.29M
EBITDA -$144.2M -$9.19M -$10.93M -$15.55M -$18.94M -$26.82M -$21.52M -$25.04M
Interest Income $999K $82K $164K $338K $342K $437K $624K $938K
Net Income -$144.5M -$2.76M -$1.17M -$9.10M -$18.74M -$26.72M -$21.24M -$24.32M
Basic EPS -$10.19 -$85.56 -$34.22 -- -$32.08 -$1,488.67 -$1,206.33 --
Diluted EPS -$10.19 -$85.56 -$34.22 -- -$32.08 -$1,488.67 -$1,206.33 --
Basic Shares Outstanding 1.1M 33.5K 33.5K -- 584.1K 17.9K 17.6K --
Diluted Shares Outstanding 1.1M 33.5K 33.5K -- 584.1K 17.9K 17.6K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $28.69M $71.64M $86.89M $38.25M $84.70M $19.84M $1.21M
Cash & Short-Term Investments $28.69M $71.64M $86.89M $38.25M $84.70M $19.84M $1.21M
Other Current Assets $664K $646K $295K $118K $219K -- --
Total Current Assets $34.65M $75.81M $88.94M $41.73M $87.83M $20.68M $1.54M
Property, Plant & Equipment, Net $102K $1.88M $2.73M $3.57M $3.69M $693K --
Long-Term Investments -- -- -- -- -- $100.3M $100.2M
Other Non-Current Assets $113K $820K $1.34M $759K $645K $298K --
Total Non-Current Assets $1.13M $4.09M $5.95M $6.63M $5.82M $2.67M $100.2M
Total Assets $35.78M $79.90M $94.89M $48.36M $93.65M $23.36M $101.7M
Accounts Payable $6.22M $4.03M $4.15M $1.77M $3.92M $1.42M --
Other Current Liabilities -- -- -- $194K $585K $149K --
Total Current Liabilities $13.20M $15.24M $12.37M $7.07M $8.02M $4.01M $111K
Other Non-Current Liabilities $2.26M $2.26M $2.26M $2.35M $643K $853K --
Total Non-Current Liabilities $18.43M $2.99M $4.08M $5.31M $16.12M $10.63M $3.50M
Total Liabilities $31.63M $18.23M $16.45M $12.37M $24.14M $14.65M $3.61M
Total Debt (incl. Leases) $1.24M $1.81M $2.79M $1.09M $760K $485K --
Common Stock $3.0K $2.0K $1.0K $4.0K $4.0K $1.0K --
Retained Earnings -$316.7M -$240.9M -$169.6M -$105.1M -$67.45M -$36.81M $2.0K
Total Stockholders' Equity $4.15M $61.67M $78.44M $35.99M $69.52M -$35.13M -$4.73M
Total Equity $4.15M $61.67M $78.44M $35.99M $69.52M -$35.13M $101.7M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $135.3M $7.31M $14.14M $28.69M $50.90M $39.51M $48.80M $71.64M
Cash & Short-Term Investments $135.3M $7.31M $14.14M $28.69M $50.90M $39.51M $48.80M $71.64M
Accounts Receivable, Net $8.00M -- -- -- -- -- -- --
Other Current Assets $636K $255K $405K $664K $863K $867K $854K $646K
Total Current Assets $147.3M $11.57M $20.29M $34.65M $54.56M $42.97M $53.17M $75.81M
Property, Plant & Equipment, Net $57K $60K $81K $102K $1.10M $1.33M $1.60M $1.88M
Other Non-Current Assets $18K $43K $77K $113K $150K $192K $532K $820K
Total Non-Current Assets $142K $231K $892K $1.13M $2.90M $3.50M $4.42M $4.09M
Total Assets $147.4M $11.80M $21.18M $35.78M $57.47M $46.47M $57.60M $79.90M
Accounts Payable $3.76M $2.78M $2.44M $6.22M $9.17M $8.03M $3.00M $4.03M
Total Current Liabilities $13.91M $7.84M $9.00M $13.20M $21.04M $20.50M $12.33M $15.24M
Other Non-Current Liabilities $1.30M -- $2.26M $2.26M $2.26M $2.26M $2.26M $2.26M
Total Non-Current Liabilities $6.98M $2.54M $8.79M $18.43M $24.86M $2.46M $3.02M $2.99M
Total Liabilities $20.89M $10.39M $17.78M $31.63M $45.90M $22.96M $15.35M $18.23M
Total Debt (incl. Leases) $69K $270K $757K $1.24M $1.70M $2.15M $2.59M $1.81M
Common Stock $3.0K $3.0K $3.0K $3.0K $3.0K $2.0K $2.0K $2.0K
Retained Earnings -$465.1M -$320.6M -$317.8M -$316.7M -$307.6M -$288.8M -$262.1M -$240.9M
Total Stockholders' Equity -$140.2M $1.41M $3.40M $4.15M $11.57M $23.50M $42.24M $61.67M
Total Equity -$140.2M $1.41M $3.40M $4.15M $11.57M $23.50M $42.24M $61.67M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$75.80M -$71.27M -$64.47M $37.70M $30.60M -$31.67M
Depreciation & Amortization $1.06M $1.37M $1.11M $975K $377K --
Stock-Based Compensation $6.71M $6.62M $5.21M $4.09M $1.05M $1.21M
Change in Receivables -- -- -- -- $600K --
Change in Payables $2.19M -$122K $2.38M -$2.15M $2.94M $358K
Operating Cash Flow -$77.16M -$62.60M -$52.07M -$45.86M -$33.68M -$18.27M
Investing Cash Flow $5.0K -$532K -$267K -$576K -$2.43M $198K
Common Stock Issued $6.45M $47.20M $101.5M $28K -- --
Financing Cash Flow $34.21M $47.88M $101.0M $55K $101.0M $11.29M
Net Change in Cash -$42.95M -$15.25M $48.64M -$46.38M $64.86M -$443K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$144.5M -$2.76M -$1.17M -$9.10M -$18.74M -$26.72M -$21.24M -$24.32M
Depreciation & Amortization $17K $21K $21K $290K $229K $258K $279K $245K
Stock-Based Compensation $1.22M $764K $423K $1.66M $1.42M $1.82M $1.81M $1.97M
Change in Payables -$2.77M $339K -$3.78M -$2.95M $1.13M $5.05M -$1.04M $957K
Operating Cash Flow -$5.50M -$6.92M -$14.55M -$21.87M -$17.00M -$15.45M -$22.84M -$21.13M
Investing Cash Flow -- -- -- $0 $0 $1.0K $4.0K -$76K
Common Stock Issued -- -- $6.50M -- -- -- -- $0
Financing Cash Flow -- -- -- -- -- -- -- $345K
Net Change in Cash $128.0M -$6.83M -$14.55M -$22.21M $11.39M -$9.29M -$22.84M -$20.86M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -1826.1% -115.6% -82.2% -104.7% -44.1% --
Return on Assets (ROA) -211.9% -89.2% -67.9% -77.9% -32.7% -135.6%
Current Ratio 2.62x 4.98x 7.19x 5.91x 10.95x 5.16x
Quick Ratio 2.17x 4.70x 7.02x 5.41x 10.56x 4.94x
Debt to Equity 0.30x 0.03x 0.04x 0.03x 0.01x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -2248.5% -1639.2% -1826.1% -786.6% -386.9% -186.5% -115.6%
Return on Assets (ROA) -106.8% -269.2% -263.1% -211.9% -158.4% -195.7% -136.8% -89.2%
Current Ratio 10.59x 1.47x 2.26x 2.62x 2.59x 2.10x 4.31x 4.98x
Quick Ratio 10.30x 0.93x 1.57x 2.17x 2.42x 1.93x 3.96x 4.70x
Debt to Equity -- 0.19x 0.22x 0.30x 0.15x 0.09x 0.06x 0.03x
Source: SEC EDGAR CompanyFacts (CIK 0001788028) · from December 31, 2019 Data through September 30, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal